1. Deep immunophenotyping at the single-cell level identifies a combination of anti-IL-17 and checkpoint blockade as an effective treatment in a preclinical model of data-guided personalized immunotherapy. Issue 2 (22nd October 2020) Authors: Nagaoka, Koji; Shirai, Masataka; Taniguchi, Kiyomi; Hosoi, Akihiro; Sun, Changbo; Kobayashi, Yukari; Maejima, Kazuhiro; Fujita, Masashi; Nakagawa, Hidewaki; Nomura, Sachiyo; Kakimi, Kazuhiro Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Deep immunophenotyping at the single-cell level identifies a combination of anti-IL-17 and checkpoint blockade as an effective treatment in a preclinical model of data-guided personalized immunotherapy. Issue 2 (22nd October 2020) Authors: Nagaoka, Koji; Shirai, Masataka; Taniguchi, Kiyomi; Hosoi, Akihiro; Sun, Changbo; Kobayashi, Yukari; Maejima, Kazuhiro; Fujita, Masashi; Nakagawa, Hidewaki; Nomura, Sachiyo; Kakimi, Kazuhiro Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Deep immunophenotyping at the single-cell level identifies a combination of anti-IL-17 and checkpoint blockade as an effective treatment in a preclinical model of data-guided personalized immunotherapy. Issue 2 (22nd October 2020) Authors: Nagaoka, Koji; Shirai, Masataka; Taniguchi, Kiyomi; Hosoi, Akihiro; Sun, Changbo; Kobayashi, Yukari; Maejima, Kazuhiro; Fujita, Masashi; Nakagawa, Hidewaki; Nomura, Sachiyo; Kakimi, Kazuhiro Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Deep immunophenotyping at the single-cell level identifies a combination of anti-IL-17 and checkpoint blockade as an effective treatment in a preclinical model of data-guided personalized immunotherapy. Issue 2 (22nd October 2020) Authors: Nagaoka, Koji; Shirai, Masataka; Taniguchi, Kiyomi; Hosoi, Akihiro; Sun, Changbo; Kobayashi, Yukari; Maejima, Kazuhiro; Fujita, Masashi; Nakagawa, Hidewaki; Nomura, Sachiyo; Kakimi, Kazuhiro Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Deep immunophenotyping at the single-cell level identifies a combination of anti-IL-17 and checkpoint blockade as an effective treatment in a preclinical model of data-guided personalized immunotherapy. Issue 2 (22nd October 2020) Authors: Nagaoka, Koji; Shirai, Masataka; Taniguchi, Kiyomi; Hosoi, Akihiro; Sun, Changbo; Kobayashi, Yukari; Maejima, Kazuhiro; Fujita, Masashi; Nakagawa, Hidewaki; Nomura, Sachiyo; Kakimi, Kazuhiro Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Deep immunophenotyping at the single-cell level identifies a combination of anti-IL-17 and checkpoint blockade as an effective treatment in a preclinical model of data-guided personalized immunotherapy. Issue 2 (22nd October 2020) Authors: Nagaoka, Koji; Shirai, Masataka; Taniguchi, Kiyomi; Hosoi, Akihiro; Sun, Changbo; Kobayashi, Yukari; Maejima, Kazuhiro; Fujita, Masashi; Nakagawa, Hidewaki; Nomura, Sachiyo; Kakimi, Kazuhiro Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Deep immunophenotyping at the single-cell level identifies a combination of anti-IL-17 and checkpoint blockade as an effective treatment in a preclinical model of data-guided personalized immunotherapy. Issue 2 (22nd October 2020) Authors: Nagaoka, Koji; Shirai, Masataka; Taniguchi, Kiyomi; Hosoi, Akihiro; Sun, Changbo; Kobayashi, Yukari; Maejima, Kazuhiro; Fujita, Masashi; Nakagawa, Hidewaki; Nomura, Sachiyo; Kakimi, Kazuhiro Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Deep immunophenotyping at the single-cell level identifies a combination of anti-IL-17 and checkpoint blockade as an effective treatment in a preclinical model of data-guided personalized immunotherapy. Issue 2 (22nd October 2020) Authors: Nagaoka, Koji; Shirai, Masataka; Taniguchi, Kiyomi; Hosoi, Akihiro; Sun, Changbo; Kobayashi, Yukari; Maejima, Kazuhiro; Fujita, Masashi; Nakagawa, Hidewaki; Nomura, Sachiyo; Kakimi, Kazuhiro Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗